Evidence map›Paper›PMID 39457428›Full record

ReviewGenes2024

Chromosome 15q11-q13 Duplication Syndrome: A Review of the Literature and 14 New Cases.

Maria Bisba, Christina Malamaki, Pantelis Constantoulakis, Spiros Vittas

Abstract readReview
In one paragraph

Review in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Special Issue: Genetic Basis of Autism Spectrum Disorder.International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria BisbaMicroGenome, 25th Martiou 55 Str., 564 29 Thessaloniki, Greece.ORCID 0009-0009-1189-4509
Christina MalamakiGenotypos Science Labs Medical SA, 3-5 Ilision Str., 115 28 Athens, Greece.
Pantelis ConstantoulakisGenotypos Science Labs Medical SA, 3-5 Ilision Str., 115 28 Athens, Greece.ORCID 0000-0001-6121-6364
Spiros VittasMicroGenome, 25th Martiou 55 Str., 564 29 Thessaloniki, Greece.ORCID 0000-0003-2879-6074

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 15q11.2q13 chromosomal region is particularly susceptible to chromosomal rearrangements due to low-copy repeats (LCRs) located inside this area. Specific breakpoints (BP1-BP5) that lead to deletions and duplications of variable size have been identified. Additionally, this specific region contains several imprinted genes, giving rise to complex syndromes (Prader-Willi, Angelman and 15q11-q13 duplication syndromes). 15q11.2-q13 duplication syndrome has been associated with neurodevelopmental disorders (hypotonia, developmental delay, speech delay and seizures) and ASD but is characterized by variable expressivity and reduced penetrance, features that make genetic counseling a complex procedure especially in prenatal cases. In the present study, a total of 14 pre- and postnatal cases were diagnosed as 15q11.2q13 duplication carriers using Affymetrix CytoScan 750 K array-CGH, and our analysis combined these with 120 cases existing in the literature. The inheritance pattern of the cases of this study is unknown, but as a review of the literature revealed, 62.96% of the affected carriers inherited the duplicated area from their mother. The combined results of this analysis (the present study and the literature) show that in the majority of the cases, the phenotype is a compound phenotype, with clinical characteristics that include ASD, intellectual disability, developmental delay and an absence of speech. The aim of this paper is to deliver new possibilities to genetic counseling that can be provided in prenatal and postnatal cases as the phenotype of 15q11.2q13 microduplication carriers cannot be fully predicted; so, clinical diagnoses should be a combination of molecular findings and clinical manifestations that are present.

Indexed as

Chromosomes, Human, Pair 15AdolescentChildChild, PreschoolChromosome AberrationsChromosome DuplicationComparative Genomic HybridizationFemaleHumansInfantIntellectual DisabilityMalePhenotypeTrisomyarray-CGHchromosome 15q11-q13 duplication syndromegenetic syndromesneurodevelopmental disordersreduced penetrancevariable expressivity

Identifiers

PMID39457428
PMCPMC11507414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.